Clinical trial
VACcination In Methotrexate Treated Rheumatoid Arthritis Patients (VACIMRA)
To estimate the rate of immunological answer 1 month after antipneumococcal vaccination by the conjugated vaccine Prevenar13 in patients suffered from rheumatoid polyarthritis and who begin a treatement by methotrexate either in the same time, either 1 month later.
| Category | Value |
|---|---|
| Study start date | 2013-09-10 |